Literature DB >> 12117924

Generation and characterization of human monoclonal scFv antibodies against Helicobacter pylori antigens.

Nicole Reiche1, Andreas Jung, Thomas Brabletz, Tanja Vater, Thomas Kirchner, Gerhard Faller.   

Abstract

Infection with Helicobacter pylori is chronic despite a vigorous cellular and humoral immune response and causes severe pathology in some patients. In this study, phage display was used as a new approach in order to investigate the role of the host's humoral immune response in the pathogenesis of H. pylori gastritis. Human monoclonal single-chain Fv (scFv) antibody fragments against H. pylori cell lysate and the H. pylori urease were isolated from an immune phage display library, constructed from peripheral blood lymphocytes of an H. pylori-infected patient. After affinity selection, 23% of the clones tested showed binding activity against a lysate of the H. pylori Sydney strain in enzyme-linked immunosorbent assay (ELISA) and 9% bound the H. pylori urease. Further characterization by PCR-fingerprint analysis and sequencing revealed that two closely related H. pylori binders and one antiurease scFv could be isolated. The selected scFvs were highly specific as analyzed by ELISA and immunoblots using various bacterial lysates and recombinant proteins. Analysis of the humoral immune response following H. pylori infection using human monoclonal antibodies might contribute to a better understanding of the pathogenesis of the disease. Moreover, using immune phage display libraries, it might be possible for relevant epitopes of H. pylori antigens to be determined, which might be of use for vaccine development.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12117924      PMCID: PMC128126          DOI: 10.1128/IAI.70.8.4158-4164.2002

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  29 in total

1.  Phage antibodies: filamentous phage displaying antibody variable domains.

Authors:  J McCafferty; A D Griffiths; G Winter; D J Chiswell
Journal:  Nature       Date:  1990-12-06       Impact factor: 49.962

2.  Relationship of anti-Lewis x and anti-Lewis y antibodies in serum samples from gastric cancer and chronic gastritis patients to Helicobacter pylori-mediated autoimmunity.

Authors:  M A Heneghan; C F McCarthy; D Janulaityte; A P Moran
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

3.  Concurrent enteric helminth infection modulates inflammation and gastric immune responses and reduces helicobacter-induced gastric atrophy.

Authors:  J G Fox; P Beck; C A Dangler; M T Whary; T C Wang; H N Shi; C Nagler-Anderson
Journal:  Nat Med       Date:  2000-05       Impact factor: 53.440

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Selection of human single chain Fv antibody fragments binding and inhibiting Helicobacter pylori urease.

Authors:  M Houimel; I Corthesy-Theulaz; I Fisch; C Wong; B Corthesy; J Mach; R Finnern
Journal:  Tumour Biol       Date:  2001 Jan-Feb

6.  Mitogenic autoantibodies in Helicobacter pylori-associated stomach cancerogenesis.

Authors:  F Hensel; C Knörr; R Hermann; V Krenn; H K Müller-Hermelink; H P Vollmers
Journal:  Int J Cancer       Date:  1999-04-12       Impact factor: 7.396

7.  Helicobacter pylori infection induces antibodies cross-reacting with human gastric mucosa.

Authors:  R Negrini; L Lisato; I Zanella; L Cavazzini; S Gullini; V Villanacci; C Poiesi; A Albertini; S Ghielmi
Journal:  Gastroenterology       Date:  1991-08       Impact factor: 22.682

8.  Effects of unpaired cysteines on yield, solubility and activity of different recombinant antibody constructs expressed in E. coli.

Authors:  A Schmiedl; F Breitling; C H Winter; I Queitsch; S Dübel
Journal:  J Immunol Methods       Date:  2000-08-28       Impact factor: 2.303

9.  Helicobacter pylori-antigen-binding fragments expressed on the filamentous M13 phage prevent bacterial growth.

Authors:  J Cao; Y Sun; T Berglindh; B Mellgård; Z Li; B Mårdh; S Mårdh
Journal:  Biochim Biophys Acta       Date:  2000-03-06

10.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

View more
  9 in total

Review 1.  Development of anti-infectives using phage display: biological agents against bacteria, viruses, and parasites.

Authors:  Johnny X Huang; Sharon L Bishop-Hurley; Matthew A Cooper
Journal:  Antimicrob Agents Chemother       Date:  2012-06-04       Impact factor: 5.191

2.  Diagnosis of Helicobacter pylori infection and diseases associated with Helicobacter pylori by Helicobacter pylori outer membrane proteins.

Authors:  Zheng Jiang; Ai-Long Huang; Xiao-Hong Tao; Pi-Long Wang
Journal:  World J Gastroenterol       Date:  2004-12-01       Impact factor: 5.742

Review 3.  Chronic inflammatory disease, lymphoid tissue neogenesis and extranodal marginal zone B-cell lymphomas.

Authors:  Richard J Bende; Febe van Maldegem; Carel J M van Noesel
Journal:  Haematologica       Date:  2009-07-16       Impact factor: 9.941

Review 4.  Developing Recombinant Antibodies by Phage Display Against Infectious Diseases and Toxins for Diagnostics and Therapy.

Authors:  Kristian Daniel Ralph Roth; Esther Veronika Wenzel; Maximilian Ruschig; Stephan Steinke; Nora Langreder; Philip Alexander Heine; Kai-Thomas Schneider; Rico Ballmann; Viola Fühner; Philipp Kuhn; Thomas Schirrmann; André Frenzel; Stefan Dübel; Maren Schubert; Gustavo Marçal Schmidt Garcia Moreira; Federico Bertoglio; Giulio Russo; Michael Hust
Journal:  Front Cell Infect Microbiol       Date:  2021-07-07       Impact factor: 5.293

5.  Identification of broadly protective human antibodies to Pseudomonas aeruginosa exopolysaccharide Psl by phenotypic screening.

Authors:  Antonio DiGiandomenico; Paul Warrener; Melissa Hamilton; Sandrine Guillard; Peter Ravn; Ralph Minter; Maria Margarita Camara; Vignesh Venkatraman; Randall S Macgill; Jia Lin; Qun Wang; Ashley Elaine Keller; Jessica C Bonnell; Mladen Tomich; Lutz Jermutus; Michael P McCarthy; David A Melnick; Joann A Suzich; C Kendall Stover
Journal:  J Exp Med       Date:  2012-06-25       Impact factor: 14.307

Review 6.  Phage display-based strategies for cloning and optimization of monoclonal antibodies directed against human pathogens.

Authors:  Nicola Clementi; Nicasio Mancini; Laura Solforosi; Matteo Castelli; Massimo Clementi; Roberto Burioni
Journal:  Int J Mol Sci       Date:  2012-07-04       Impact factor: 6.208

7.  Diagnostic Potential of Recombinant scFv Antibodies Generated Against Hemagglutinin Protein of Influenza A Virus.

Authors:  Roopali Rajput; Gaurav Sharma; Varsha Rawat; Anju Gautam; Binod Kumar; B Pattnaik; H K Pradhan; Madhu Khanna
Journal:  Front Immunol       Date:  2015-09-02       Impact factor: 7.561

Review 8.  Infectious disease antibodies for biomedical applications: A mini review of immune antibody phage library repertoire.

Authors:  Jing Yi Lai; Theam Soon Lim
Journal:  Int J Biol Macromol       Date:  2020-07-08       Impact factor: 6.953

Review 9.  Recombinant antibodies for diagnostics and therapy against pathogens and toxins generated by phage display.

Authors:  Philipp Kuhn; Viola Fühner; Tobias Unkauf; Gustavo Marcal Schmidt Garcia Moreira; André Frenzel; Sebastian Miethe; Michael Hust
Journal:  Proteomics Clin Appl       Date:  2016-06-21       Impact factor: 3.494

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.